Kodiak Sciences Future Growth
Future criteria checks 0/6
Kodiak Sciences is forecast to grow earnings and revenue by 1.8% and 61% per annum respectively while EPS is expected to grow by 7.5% per annum.
Key information
1.8%
Earnings growth rate
7.5%
EPS growth rate
| Biotechs earnings growth | 26.8% |
| Revenue growth rate | 61.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 20 Nov 2024 |
Recent future growth updates
Recent updates
We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate
Dec 13
Kodiak: Tarcocimab Faces High Barriers To Entry Despite Resurrection (Rating Upgrade)
Nov 15We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully
Aug 02We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully
Apr 17We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully
Dec 29We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate
Sep 09Is Kodiak Sciences (NASDAQ:KOD) In A Good Position To Deliver On Growth Plans?
May 26We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully
Jan 04Here's Why We're Watching Kodiak Sciences' (NASDAQ:KOD) Cash Burn Situation
Sep 25GreenWood Investors - Kodiak Sciences: The Busted Biotech World
Aug 25Kodiak Sciences FQ1 2022 Earnings Preview
Aug 07Is Kodiak Sciences (NASDAQ:KOD) In A Good Position To Invest In Growth?
May 18Kodiak Sciences: Potential For Comeback After Trial Setback
May 17Kodiak Sciences: KSI-301 Disappoints
Feb 25Highlighting Kodiak Sciences: A Great Buy Here Ahead Of Phase 3 Wet AMD Data For KSI-301 This Quarter
Feb 15We're Hopeful That Kodiak Sciences (NASDAQ:KOD) Will Use Its Cash Wisely
Jan 24Here's Why We're Not Too Worried About Kodiak Sciences' (NASDAQ:KOD) Cash Burn Situation
Oct 11Kodiak Sciences: Our Current Take On This Mid-Cap Biotech Company
Jul 19Kodiak Sciences EPS in-line
May 10Kodiak Sciences hits the capital raise button; shares dip after hours
Nov 16Kodiak Sciences EPS misses by $0.12
Nov 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 45 | -245 | -266 | N/A | 1 |
| 12/31/2026 | N/A | -321 | -302 | N/A | 1 |
| 12/31/2025 | N/A | -222 | -197 | -135 | 3 |
| 12/31/2024 | N/A | -179 | -196 | -66 | 3 |
| 9/30/2024 | N/A | -192 | -147 | -119 | N/A |
| 6/30/2024 | N/A | -198 | -159 | -131 | N/A |
| 3/31/2024 | N/A | -233 | -176 | -147 | N/A |
| 12/31/2023 | N/A | -260 | -196 | -154 | N/A |
| 9/30/2023 | N/A | -271 | -197 | -177 | N/A |
| 6/30/2023 | N/A | -298 | -224 | -197 | N/A |
| 3/31/2023 | N/A | -309 | -252 | -211 | N/A |
| 12/31/2022 | N/A | -334 | -254 | -206 | N/A |
| 9/30/2022 | N/A | -357 | -263 | -210 | N/A |
| 6/30/2022 | N/A | -347 | -286 | -209 | N/A |
| 3/31/2022 | N/A | -312 | -266 | -191 | N/A |
| 12/31/2021 | N/A | -267 | -246 | -182 | N/A |
| 9/30/2021 | N/A | -220 | -208 | -150 | N/A |
| 6/30/2021 | N/A | -189 | -150 | -123 | N/A |
| 3/31/2021 | N/A | -159 | -114 | -100 | N/A |
| 12/31/2020 | N/A | -133 | -90 | -83 | N/A |
| 9/30/2020 | N/A | -102 | -70 | -68 | N/A |
| 6/30/2020 | N/A | -78 | -51 | -51 | N/A |
| 3/31/2020 | N/A | -64 | -50 | -50 | N/A |
| 12/31/2019 | N/A | -47 | -40 | -39 | N/A |
| 9/30/2019 | N/A | -46 | -37 | -36 | N/A |
| 6/30/2019 | N/A | -44 | -34 | -33 | N/A |
| 3/31/2019 | N/A | -41 | -26 | -25 | N/A |
| 12/31/2018 | N/A | -41 | -30 | -29 | N/A |
| 9/30/2018 | N/A | -38 | -26 | -26 | N/A |
| 6/30/2018 | N/A | -32 | N/A | -26 | N/A |
| 3/31/2018 | N/A | -31 | N/A | -25 | N/A |
| 12/31/2017 | N/A | -28 | N/A | -18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KOD is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: KOD is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: KOD is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: KOD is forecast to have no revenue next year.
High Growth Revenue: KOD is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if KOD's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 00:32 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kodiak Sciences Inc. is covered by 17 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Huidong Wang | Barclays |
| Anita Dushyanth | Berenberg |
| Matthew Luchini | BMO Capital Markets Equity Research |